Measure the Meridian Energy Change of Terminal Hospice Patient Via

Status Completed

Clinical Trial Summary

In the hospice ward, there are lots of suffered hospital patients with multiple physical discomfort related to terminal disease. Investigators want to use an objective measure instrument to monitor the effects of complementary and alternative medicine and clinical symptoms. First, investigators use the Meridian Energy Analysis Device (MEAD) to measure the bilateral 12 Yuan points (primary points) of terminal hospice patients. It provides the prediction value between terminal disease and the change of different meridian energy. Besides, the meridian energy value maybe predict the survival period. Then, the intervention of complementary and alternative medicine can also monitor via MEAD.

Clinical Trial Description

In the hospice ward, there are lots of suffered hospital patients with multiple physical discomfort related to terminal disease. It may be caused by cancer or multiple kinds of organ failure. The terminal hospital patients have symptoms such as pain, dyspnea, fatigue, nausea, vomiting, poor appetite, constipation, ileus or edema…, etc. Investigators want to use an objective measure instrument to monitor the effects of complementary and alternative medicine. First, investigators use the Meridian Energy Analysis Device (MEAD) to measure the bilateral 12 Yuan points (primary points) of terminal hospice patients (divided to cancer, multiple kinds of organ failure). It provides the prediction value between terminal disease and the change of different meridian energy. Besides, the meridian energy value maybe predict the survival period. Then, investigators use the intervention of complementary and alternative medicine (like infrared lamp and acupressure…, etc.) to improve the quality of life in the terminal hospice patients. Also, investigators will use the Meridian Energy Analysis Device, pain scale, vital signs and quality of life scale (SF-36) to evaluate the effects of complementary and alternative medicine. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03939221
Study type	Interventional
Source	Changhua Christian Hospital
Contact
Status	Completed
Phase	N/A
Start date	February 18, 2019
Completion date	October 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01952184` - Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.	N/A
Completed	`NCT00993343` - Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation	Phase 3
Recruiting	`NCT04808466` - Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy	Phase 2
Not yet recruiting	`NCT04845490` - Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy	Phase 2
Recruiting	`NCT03291275` - Survival Outcomes of Uterine Malignancies in Chinese Population	N/A
Recruiting	`NCT05720858` - Telerehabilitation in Survival Breast Cancer Patients	N/A
Completed	`NCT03351920` - Ventilation's Parameters Applied in Emergency Medicine. A Prospective Observational Study
Not yet recruiting	`NCT06147180` - Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
Recruiting	`NCT04472403` - Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
Recruiting	`NCT03739944` - Different Surgical Approaches in Patients of Early-stage Cervical Cancer	Phase 3
Not yet recruiting	`NCT02960061` - Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer	Phase 3
Recruiting	`NCT03738969` - Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
Completed	`NCT03134807` - The Very Old Intensive Care Patient: A Multinational Prospective Observation Study
Completed	`NCT03084809` - Chemotherapy Combined With CIK Treating Colon Cancer	Phase 4
Completed	`NCT03642041` - Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients
Recruiting	`NCT04351308` - Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma	Phase 2
Recruiting	`NCT03920033` - Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy	N/A
Recruiting	`NCT05540119` - Swedish Oesophago-Gastric Study
Completed	`NCT04519450` - Ultrasound of Accessory Respiratory Muscles
Active, not recruiting	`NCT01835821` - Clinical Study of Porcelain-fused and IPS e.Max CAD Crowns	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Measure the Meridian Energy Change of Terminal Hospice Patient Via Meridian Energy Analysis Device

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms